The abnormal deposition of modified Tau is the pathognomonic hallmark of many neurodegenerative diseases called “tauopathies”, including but not limited to Alzheimer’s disease (AD), progressive supranuclear palsy (PSP), and chronic traumatic encephalopathy (CTE) (Lee et al., 2001; Arendt et al., 2016). This evidence concerns the gene MAPT and tauopathy.